1887
Research Open Access
Like 0

Abstract

Background

Laboratory-confirmed cases of Shiga toxin-producing (STEC) have been notifiable to the National Notification System for Infectious Diseases in Switzerland since 1999. Since 2015, a large increase in case numbers has been observed. Around the same time, syndromic multiplex PCR started to replace other diagnostic methods in standard laboratory practice for gastrointestinal pathogen testing, suggesting that the increase in notified cases is due to a change in test practices and numbers.

Aim

This study examined the impact of changes in diagnostic methods, in particular the introduction of multiplex PCR panels, on routine STEC surveillance data in Switzerland.

Methods

We analysed routine laboratory data from 11 laboratories, which reported 61.9% of all STEC cases from 2007 to 2016 to calculate the positivity, i.e. the rate of the number of positive STEC tests divided by the total number of tests performed.

Results

The introduction of multiplex PCR had a strong impact on STEC test frequency and identified cases, with the number of tests performed increasing sevenfold from 2007 to 2016. Still, age- and sex-standardised positivity increased from 0.8% in 2007 to 1.7% in 2016.

Conclusion

Increasing positivity suggests that the increase in case notifications cannot be attributed to an increase in test numbers alone. Therefore, we cannot exclude a real epidemiological trend for the observed increase. Modernising the notification system to address current gaps in information availability, e.g. diagnostic methods, and improved triangulation of clinical presentation, diagnostic and serotype information are needed to deal with emerging disease and technological advances.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2020.25.33.1900584
2020-08-20
2020-11-26
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2020.25.33.1900584
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/25/33/eurosurv-25-33-2.html?itemId=/content/10.2807/1560-7917.ES.2020.25.33.1900584&mimeType=html&fmt=ahah

References

  1. World Health Organization (WHO). Fact sheet. E. coli. Geneva: WHO. [Accessed 12 Oct 2018]. Available from: http://www.who.int/en/news-room/fact-sheets/detail/e-coli
  2. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005;365(9464):1073-86.  https://doi.org/10.1016/S0140-6736(05)71144-2  PMID: 15781103 
  3. Chart H. Are all infections with Escherichia coli O157 associated with cattle? Lancet. 1998;352(9133):1005.  https://doi.org/10.1016/S0140-6736(05)60072-4  PMID: 9759740 
  4. Grif K, Orth D, Lederer I, Berghold C, Roedl S, Mache CJ, et al. Importance of environmental transmission in cases of EHEC O157 causing hemolytic uremic syndrome. Eur J Clin Microbiol Infect Dis. 2005;24(4):268-71.  https://doi.org/10.1007/s10096-005-1320-z  PMID: 15902533 
  5. Vernozy-Rozand C. Detection of Escherichia coli O157:H7 and other verocytotoxin-producing E. coli (VTEC) in food. J Appl Microbiol. 1997;82(5):537-51.  https://doi.org/10.1111/j.1365-2672.1997.tb03584.x  PMID: 9172396 
  6. European Centre for Disease Prevention and Control (ECDC). Shiga-toxin/verocytotoxin-producing Escherichia coli (STEC/VTEC) infection. In: ECDC. Annual epidemiological report for 2018. Stockholm: ECDC; 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/shiga-toxin-verocytototoxin-escherichia-coli-annual-epidemiological-report-2018.pdf
  7. Schmutz C. Foodborne diseases in Switzerland: Understanding the burden of illness pyramid to improve Swiss infectious disease surveillance [dissertation]. Basel, Switzerland: University of Basel, Faculty of Science; 2018.
  8. Buchholz U, Bernard H, Werber D, Böhmer MM, Remschmidt C, Wilking H, et al. German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med. 2011;365(19):1763-70.  https://doi.org/10.1056/NEJMoa1106482  PMID: 22029753 
  9. Germinario C, Caprioli A, Giordano M, Chironna M, Gallone MS, Tafuri S, et al. , all participants of the Outbreak investigation team. Community-wide outbreak of haemolytic uraemic syndrome associated with Shiga toxin 2-producing Escherichia coli O26:H11 in southern Italy, summer 2013. Euro Surveill. 2016;21(38):30343.  https://doi.org/10.2807/1560-7917.ES.2016.21.38.30343  PMID: 27684204 
  10. Usein C-R, Ciontea AS, Militaru CM, Condei M, Dinu S, Oprea M, et al. Molecular characterisation of human Shiga toxin-producing Escherichia coli O26 strains: results of an outbreak investigation, Romania, February to August 2016. Euro Surveill. 2017;22(47):17-00148.  https://doi.org/10.2807/1560-7917.ES.2017.22.47.17-00148  PMID: 29183554 
  11. Majowicz SE, Scallan E, Jones-Bitton A, Sargeant JM, Stapleton J, Angulo FJ, et al. Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis. Foodborne Pathog Dis. 2014;11(6):447-55.  https://doi.org/10.1089/fpd.2013.1704  PMID: 24750096 
  12. Hächler H, Stephan R. Auffälliger Anstieg der Meldezahlen enterohämorrhagischer E. coli-Infektionen über die letzten Monate in der Schweiz: Einfluss neuer Multiplex PCR-Methoden in der Primär-Diagnostik? [Striking increase in the number of reports of enterohaemorrhagic E. coli infections over the last months in Switzerland: Influence of new multiplex PCR methods in primary diagnostics?]. BAG Bulletin.2015;52:988-90.German.
  13. Binnicker MJ. Multiplex molecular panels for diagnosis of gastrointestinal infection: Performance, result interpretation, and cost-effectiveness. J Clin Microbiol. 2015;53(12):3723-8.  https://doi.org/10.1128/JCM.02103-15  PMID: 26311866 
  14. Swissmedic.Laboratory establishment licences issued under the old process. Bern: Swissmedic. [Accessed 24 Jan 2019]. Available from: https://www.swissmedic.ch/swissmedic/en/home/humanarzneimittel/bewilligungen_zertifikate/microbiological-laboratories/bewilligungsinhaber.html
  15. Schmutz C, Burki D, Frei R, Mäusezahl-Feuz M, Mäusezahl D. Testing for Chlamydia trachomatis: time trends in positivity rates in the canton of Basel-Stadt, Switzerland. Epidemiol Infect. 2013;141(9):1953-64.  https://doi.org/10.1017/S0950268812002567  PMID: 23158540 
  16. Bless PJ, Schmutz C, Sartori K, Mäusezahl D. Time trends of positivity rates from foodborne pathogen testing in Switzerland, 2003 to 2012. Swiss Med Wkly. 2017;147:w14569. PMID: 29282700 
  17. Kehl SC. Role of the laboratory in the diagnosis of enterohemorrhagic Escherichia coli infections. J Clin Microbiol. 2002;40(8):2711-5.  https://doi.org/10.1128/JCM.40.8.2711-2715.2002  PMID: 12149318 
  18. Cronquist AB, Mody RK, Atkinson R, Besser J, Tobin D’Angelo M, Hurd S, et al. Impacts of culture-independent diagnostic practices on public health surveillance for bacterial enteric pathogens. Clin Infect Dis. 2012;54(Suppl 5):S432-9.  https://doi.org/10.1093/cid/cis267  PMID: 22572666 
  19. Moran-Gilad J. How do advanced diagnostics support public health policy development? Euro Surveill. 2019;24(4):1900068.  https://doi.org/10.2807/1560-7917.ES.2019.24.4.1900068  PMID: 30696524 
  20. European Commission, Directorate-General for Health and Food Safety. Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. Official Journal of the European Union. Luxembourg: Publications Office of the European Union. 6.7.2018:L 170. Available from: https://eur-lex.europa.eu/eli/dec_impl/2018/945/oj
  21. Johnson RP, Clarke RC, Wilson JB, Read SC, Rahn K, Renwick SA, et al. Growing concerns and recent outbreaks involving non-O157:H7 serotypes of verotoxigenic Escherichia coli. J Food Prot. 1996;59(10):1112-22.  https://doi.org/10.4315/0362-028X-59.10.1112  PMID: 31195470 
  22. Rice T, Quinn N, Sleator RD, Lucey B. Changing diagnostic methods and increased detection of verotoxigenic Escherichia coli, Ireland. Emerg Infect Dis. 2016;22(9):1656-7.  https://doi.org/10.3201/eid2209.160477  PMID: 27322897 
  23. Clogher P, Hurd S, Hoefer D, Hadler JL, Pasutti L, Cosgrove S, et al. Assessment of physician knowledge and practices concerning Shiga toxin-producing Escherichia coli infection and enteric illness, 2009, Foodborne Diseases Active Surveillance Network (FoodNet). Clin Infect Dis. 2012;54(Suppl 5):S446-52.  https://doi.org/10.1093/cid/cis246  PMID: 22572668 
  24. Rivas M, Chinen I, Miliwebsky E, Masana M. Risk factors for Shiga toxin-producing Escherichia coli-associated human diseases. Microbiol Spectr. 2014;2(5).  https://doi.org/10.1128/microbiolspec.EHEC-0002-2013  PMID: 26104362 
  25. Bless PJ, Muela Ribera J, Schmutz C, Zeller A, Mäusezahl D. Acute gastroenteritis and campylobacteriosis in Swiss primary care: The viewpoint of general practitioners. PLoS One. 2016;11(9):e0161650.  https://doi.org/10.1371/journal.pone.0161650  PMID: 27603141 
  26. Davis TK, Van De Kar NCAJ, Tarr PI. Shiga toxin/verocytotoxin-producing Escherichia coli infections: Practical clinical perspectives. Microbiol Spectr. 2014;2(4):0025-2014.  PMID: 26104210 
  27. Khare R, Espy MJ, Cebelinski E, Boxrud D, Sloan LM, Cunningham SA, et al. Comparative evaluation of two commercial multiplex panels for detection of gastrointestinal pathogens by use of clinical stool specimens. J Clin Microbiol. 2014;52(10):3667-73.  https://doi.org/10.1128/JCM.01637-14  PMID: 25100818 
  28. Buss SN, Leber A, Chapin K, Fey PD, Bankowski MJ, Jones MK, et al. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis. J Clin Microbiol. 2015;53(3):915-25.  https://doi.org/10.1128/JCM.02674-14  PMID: 25588652 
  29. Stockmann C, Rogatcheva M, Harrel B, Vaughn M, Crisp R, Poritz M, et al. How well does physician selection of microbiologic tests identify Clostridium difficile and other pathogens in paediatric diarrhoea? Insights using multiplex PCR-based detection. Clin Microbiol Infect. 2015;21(2):179.e9-15.  https://doi.org/10.1016/j.cmi.2014.07.011  PMID: 25599941 
  30. Harrington SM, Buchan BW, Doern C, Fader R, Ferraro MJ, Pillai DR, et al. Multicenter evaluation of the BD max enteric bacterial panel PCR assay for rapid detection of Salmonella spp., Shigella spp., Campylobacter spp. (C. jejuni and C. coli), and Shiga toxin 1 and 2 genes. J Clin Microbiol. 2015;53(5):1639-47.  https://doi.org/10.1128/JCM.03480-14  PMID: 25740779 
  31. Stephan R, Ragettli S, Untermann F. Prevalence and characteristics of verotoxin-producing Escherichia coli (VTEC) in stool samples from asymptomatic human carriers working in the meat processing industry in Switzerland. J Appl Microbiol. 2000;88(2):335-41.  https://doi.org/10.1046/j.1365-2672.2000.00965.x  PMID: 10736003 
  32. Käppeli U, Hächler H, Giezendanner N, Beutin L, Stephan R. Human infections with non-O157 Shiga toxin-producing Escherichia coli, Switzerland, 2000-2009. Emerg Infect Dis. 2011;17(2):180-5.  https://doi.org/10.3201/eid1702.100909  PMID: 21291586 
  33. Kuehne A, Bouwknegt M, Havelaar A, Gilsdorf A, Hoyer P, Stark K, et al. Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome. Epidemiol Infect. 2016;144(15):3305-15.  https://doi.org/10.1017/S0950268816001436  PMID: 27468812 
  34. Freedman SB, Xie J, Neufeld MS, Hamilton WL, Hartling L, Tarr PI, et al. Shiga toxin–producing Escherichia coli infection, antibiotics, and risk of developing Hemolytic Uremic Syndrome: A meta-analysis. Clin Infect Dis. 2016;62(10):1251-8.  https://doi.org/10.1093/cid/ciw099  PMID: 26917812 
  35. Fierz L, Cernela N, Hauser E, Nüesch-Inderbinen M, Stephan R. Characteristics of Shigatoxin-producing Escherichia coli strains isolated during 2010-2014 from human infections in Switzerland. Front Microbiol. 2017;8:1471.  https://doi.org/10.3389/fmicb.2017.01471  PMID: 28824596 
  36. Nüesch-Inderbinen M, Morach M, Cernela N, Althaus D, Jost M, Mäusezahl M, et al. Serotypes and virulence profiles of Shiga toxin-producing Escherichia coli strains isolated during 2017 from human infections in Switzerland. Int J Med Microbiol. 2018;308(7):933-9.  https://doi.org/10.1016/j.ijmm.2018.06.011  PMID: 30042042 
  37. Marder EP, Griffin PM, Cieslak PR, Dunn J, Hurd S, Jervis R, et al. Preliminary incidence and trends of infections with pathogens transmitted commonly through food — Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2006-2017. MMWR Morb Mortal Wkly Rep. 2018;67(11):324-8.  https://doi.org/10.15585/mmwr.mm6711a3  PMID: 29565841 
  38. European Centre for Disease Prevention and Control (ECDC). Shiga-toxin/verocytotoxin-producing Escherichia coli (STEC/VTEC) infection. In: Annual Epidemiological Report for 2016. Stockholm: ECDC; 2018. [Accessed 12 Oct 2018]. Available from: https://ecdc.europa.eu/en/publications-data/shiga-toxinverocytotoxin-producing-escherichia-coli-stecvtec-infection-annual
  39. Martinez-Castillo A, Quirós P, Navarro F, Miró E, Muniesa M. Shiga toxin 2-encoding bacteriophages in human fecal samples from healthy individuals. Appl Environ Microbiol. 2013;79(16):4862-8.  https://doi.org/10.1128/AEM.01158-13  PMID: 23747705 
  40. Antikainen J, Kantele A, Pakkanen SH, Lääveri T, Riutta J, Vaara M, et al. A quantitative polymerase chain reaction assay for rapid detection of 9 pathogens directly from stools of travelers with diarrhea. Clin Gastroenterol Hepatol. 2013;11(10):1300-1307.e3.  https://doi.org/10.1016/j.cgh.2013.03.037  PMID: 23639597 
  41. Jenssen GR, Veneti L, Lange H, Vold L, Naseer U, Brandal LT. Implementation of multiplex PCR diagnostics for gastrointestinal pathogens linked to increase of notified Shiga toxin-producing Escherichia coli cases in Norway, 2007-2017. Eur J Clin Microbiol Infect Dis. 2019;38(4):801-9.  https://doi.org/10.1007/s10096-019-03475-5  PMID: 30680573 
  42. Kinnula S, Hemminki K, Kotilainen H, Ruotsalainen E, Tarkka E, Salmenlinna S, et al. Outbreak of multiple strains of non-O157 Shiga toxin-producing and enteropathogenic Escherichia coli associated with rocket salad, Finland, autumn 2016. Euro Surveill. 2018;23(35):1700666.  https://doi.org/10.2807/1560-7917.ES.2018.23.35.1700666  PMID: 30180926 
/content/10.2807/1560-7917.ES.2020.25.33.1900584
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error